Human Capital News Roundup: 'Superbugs,' doctor rating systems, drug safety, and more.
Around the country, print, broadcast and online media outlets are covering the groundbreaking work of Robert Wood Johnson Foundation (RWJF) leaders, scholars, fellows and grantees. Some recent examples:
Forbes named RWJF President and CEO Risa Lavizzo-Mourey, MD, MBA, to its annual list of the “World’s 100 Most Powerful Women.” The list includes political leaders, corporate executives, NGO heads, top government officials and a first lady.
The Academic Progression in Nursing (APIN) program has announced grants to nine states, Nurse.com reports. California, Hawaii, Massachusetts, Montana, New Mexico, New York, North Carolina, Texas, and Washington state will receive two-year, $300,000 grants to advance state and regional strategies aimed at creating a more highly educated, diverse nursing workforce. Read more about the APIN grants.
City Biz List Baltimore reports on the selection of Jason E. Farley, PhD, MPH, CRNP, to be a 2012 RWJF Nurse Faculty Scholar. He is among the 12 talented junior nurse faculty members chosen for the highly competitive program. Read more about the new cohort of Nurse Faculty Scholars.
RWJF Physician Faculty Scholars alumnus Deverick J. Anderson, MD, MPH, spoke to the Associated Press about hospital infection control and “superbugs,” or antibiotic-resistant germs. The story was picked up by USA Today, U.S. News & World Report, and CBS News, among other outlets.
“In recent years, NIH funding has not kept pace with growth in biomedical innovation, making it harder for scientists to win grants,” RWJF/U.S. Department of Veterans Affairs Clinical Scholar Gordon Sun, MD, tells Medical XPress. “Meanwhile, these five Asian countries [China, India, Singapore, South Korea and Taiwan] have pledged long-term increases in funding.” A study Sun led warns that this could result in a “brain drain” of top young researchers from the United States.
R. Adams Dudley, MD, MBA, a former grantee of the RWJF Interdisciplinary Nursing Quality Research Initiative (INQRI), spoke to KPBS about a rating system he helped create “to find the best and most cost-effective doctors.”
Science Daily reports that RWJF Investigator Award in Health Policy Research recipient Michelle M. Mello, JD, PhD, MPhil, coauthored a commentary in the New England Journal of Medicine on drug safety in the United States. Mello and her coauthors were members of an Institute of Medicine committee that authored a report on the issue, calling for more Food and Drug Administration involvement in drug innovation and drug safety.